Macular Degeneration Recruiting Phase 1 / 2 Trials for Tacrolimus (DB00864)

Also known as: Macula lutea degeneration / Retinal macula lutea degeneration / Macular luteal degeneration / Degenerative disorder of macula (disorder) / Degeneration macular

IndicationStatusPhase
DBCOND0027875 (Macular Degeneration)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06394232
Safety & Efficacy of Eyecyte-RPEā„¢ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.Treatment